Research ArticleArticle
(4-(Bis(4-Fluorophenyl)Methyl)Piperazin-1-yl)(Cyclohexyl)Methanone Hydrochloride (LDK1229): A New Cannabinoid CB1 Receptor Inverse Agonist from the Class of Benzhydryl Piperazine Analogs
Mariam M. Mahmoud, Teresa Olszewska, Hui Liu, Derek M. Shore, Dow P. Hurst, Patricia H. Reggio, Dai Lu and Debra A. Kendall
Molecular Pharmacology February 2015, 87 (2) 197-206; DOI: https://doi.org/10.1124/mol.114.095471
Mariam M. Mahmoud
Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut (M.M.M.); Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas (T.O., H. L., D.L.); Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina (D.M.S., D.P.H., P.H.R.); and Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (D.A.K.)
Teresa Olszewska
Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut (M.M.M.); Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas (T.O., H. L., D.L.); Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina (D.M.S., D.P.H., P.H.R.); and Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (D.A.K.)
Hui Liu
Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut (M.M.M.); Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas (T.O., H. L., D.L.); Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina (D.M.S., D.P.H., P.H.R.); and Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (D.A.K.)
Derek M. Shore
Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut (M.M.M.); Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas (T.O., H. L., D.L.); Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina (D.M.S., D.P.H., P.H.R.); and Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (D.A.K.)
Dow P. Hurst
Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut (M.M.M.); Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas (T.O., H. L., D.L.); Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina (D.M.S., D.P.H., P.H.R.); and Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (D.A.K.)
Patricia H. Reggio
Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut (M.M.M.); Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas (T.O., H. L., D.L.); Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina (D.M.S., D.P.H., P.H.R.); and Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (D.A.K.)
Dai Lu
Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut (M.M.M.); Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas (T.O., H. L., D.L.); Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina (D.M.S., D.P.H., P.H.R.); and Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (D.A.K.)
Debra A. Kendall
Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut (M.M.M.); Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas (T.O., H. L., D.L.); Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina (D.M.S., D.P.H., P.H.R.); and Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (D.A.K.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
CB1 Inverse Agonist LDK1229
Mariam M. Mahmoud, Teresa Olszewska, Hui Liu, Derek M. Shore, Dow P. Hurst, Patricia H. Reggio, Dai Lu and Debra A. Kendall
Molecular Pharmacology February 1, 2015, 87 (2) 197-206; DOI: https://doi.org/10.1124/mol.114.095471
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement